Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors.

Subjects

Subjects :

ANTINEOPLASTIC agents
TUMORS

Details

Language :

English

ISSN :

01676997

Volume :

35

Issue :

5

Database :

Complementary Index

Journal :

Investigational New Drugs

Publication Type :

Academic Journal

Accession number :

125326143

Full Text :

https://doi.org/10.1007/s10637-017-0479-3